SCHEMBL17486266

SCHEMBL17486266

Cc1nc(-c2ccc(-c3ccc4c(c3)C(C)(C)C(C)(C)C4(C)C)nc2)nc(N2CCCCC2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 7/20 0.37
KDM4E B2RXH2 7/20 0.37
ALDH1A1 P00352 6/20 0.37
HPGD P15428 6/20 0.37
MAPK1 P28482 4/20 0.37
TSHR P16473 3/20 0.37
CASP1 P29466 2/20 0.37
CASP7 P55210 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
ALOX15 P16050 2/20 0.37
CYP2C19 P33261 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
USP2 O75604 1/20 0.37
ATM Q13315 1/20 0.37
CNR2 P34972 3/20 0.36
PIK3R1 P27986 2/20 0.35
PIK3CA P42336 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17486096 0.92 PIK3CA (0.41) HSD17B10KDM4EALDH1A1HPGDMAPK1
SCHEMBL17486262 0.90 PIK3CA (0.48) HSD17B10KDM4EHPGDTSHRCYP1A2
SCHEMBL17486094 0.86 PIK3CA (0.38) HSD17B10KDM4EALDH1A1HPGDMAPK1
SCHEMBL17486039 0.85 PIK3CA (0.36) HSD17B10KDM4EALDH1A1HPGDMAPK1
SCHEMBL17486034 0.84 HSD17B1 (0.36) L3MBTL1
SCHEMBL19295142 0.83 PIK3CA (0.55) PIK3R1PIK3CAMTOR
SCHEMBL17486137 0.82 MTOR (0.39) PIK3R1PIK3CAMTOR
SCHEMBL17486178 0.81 L3MBTL1 (0.47) KDM4EALDH1A1HPGDSMN1; SMN2CYP3A4
SCHEMBL17485974 0.79 HSD17B1 (0.37) L3MBTL1
SCHEMBL17485965 0.79 HSD17B1 (0.36) HSD17B10ALDH1A1SMN1; SMN2ALOX15GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 HSD17B10 2888/4885KDM4E 3816/4885ALDH1A1 3721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.